ArrePath
Latest round
- Seed
Last raised
- Mar 2022
Total raised
- $20M
Investors
- 7
About ArrePath
In June 2025, ArrePath, Inc. The company provides an advanced machine learning (ML) and imaging-based drug discovery platform to identify new classes of antibiotics. It also provides drug discovery, microbiology, microscopy, and data science to develop life-saving anti-infectives. It offers phenotypic profiling and bacterial autopsies, artificial intelligence/machine learning-enabled drug design, multidimensional phenotypic screening, and proteomics.
Who invested in ArrePath
7 investors across 1 round
See all investors in ArrePath
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 3, 2022
Amount
$20M
Investors
Questions about ArrePath
Who invested in ArrePath?
ArrePath has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ArrePath raised?
ArrePath has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ArrePath last raise money?
ArrePath's most recent round on record is a Seed, in Mar 2022.
What does ArrePath do?
ArrePath is a biotechnology company.
Where is ArrePath headquartered?
ArrePath is headquartered in US.
Which VCs invest in companies like ArrePath?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ArrePath's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like ArrePath? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.